Update: Product, Substance-Use, and Demographic Characteristics of Hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, August 2019–January 2020

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Personal Author:
  Ellington, Sascha ; Salvatore, Phillip P. ; Ko, Jean ; Danielson, Melissa ; Kim, Lindsay ; Cyrus, Alissa ; Wallace, Megan ; Board, Amy ; Krishnasamy, Vikram ; King, Brian A. ; Rose, Dale ; Jones, Christopher M. ; Pollack, Lori A. ; Abbas, Amena ; Adebayo, Adebola ; Atti, Sukhshant ; Carter, Elizabeth ; Chandra, Gyan ; Eckhaus, Lindsay ; Fajardo, Geroncio ; Goyal, Sonal ; Hallowell, Benjamin ; Hamilton, Janet ; Israel, Mia ; Li, Zheng ; Loretan, Caitlin ; Lynfield, Ruth ; Melstrom, Paul ; Pomeroy, Mary ; Schrodt, Caroline ; Soroka, Stephen ; Thomas, Kimberly ; Wallace, Bailey M.
• Corporate Authors:
  Lung Injury Response Epidemiology/Surveillance Task Force
• Description:
  CDC, the Food and Drug Administration (FDA), state and local health departments, and public health and clinical stakeholders continue to investigate a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) (1). EVALI patients in Illinois, Utah, and Wisconsin acquired tetrahydrocannabinol (THC)-containing products primarily from informal sources (2,3). This report updates demographic characteristics and self-reported sources of THC- and nicotine-containing e-cigarette, or vaping, products derived from EVALI patient data reported to CDC by state health departments. As of January 7, 2020, among 1,979 (76%) patients with available data on substance use, a total of 1,620 (82%) reported using any THC-containing products, including 665 (34%) who reported exclusive THC-containing product use. Use of any nicotine-containing products was reported by 1,128 (57%) patients, including 264 (13%) who reported exclusive nicotine-containing product use. Among 809 (50%) patients reporting data on the source of THC-containing products, 131 (16%) reported acquiring their products from only commercial sources (i.e., recreational dispensaries, medical dispensaries, or both; vape or smoke shops; stores; and pop-up shops), 627 (78%) from only informal sources (i.e., friends, family, in-person or online dealers, or other sources), and 51 (6%) from both types of sources. Among 613 (54%) EVALI patients reporting nicotine-containing product use with available data on product source, 421 (69%) reported acquiring their products from only commercial sources, 103 (17%) from only informal sources, and 89 (15%) from both types of sources. Adolescents aged 13-17 years were more likely to acquire both THC- and nicotine-containing products from informal sources than were persons in older age groups. The high prevalence of acquisition of THC-containing products from informal sources by EVALI patients reinforces CDC's recommendation to not use e-cigarette, or vaping, products that contain THC, especially those acquired from informal sources. Although acquisition of nicotine-containing products through informal sources was not common overall, it was common among persons aged <18 years. While the investigation continues, CDC recommends that the best way for persons to ensure that they are not at risk is to consider refraining from the use of all e-cigarette, or vaping, products.
• Subjects:
  Adolescent Adult Aged Aged, 80 And Over Disease Outbreaks Dronabinol Electronic Nicotine Delivery Systems Female Full Report Hospitalization Humans Lung Injury Male Middle Aged Vaping Young Adult

  More +
• Source:
  MMWR Morbidity Mortal Weekly Rep. 69(2):44-49
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  31945038
• Pubmed Central ID:
  PMC6973348
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Pages in Document:
  6 pdf pages
• Volume:
  69
• Issue:
  2
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:909d762b8839452315dfdfcb5aa1094146bd48c57a17c45c50eaaa692c27c879e2b556f9ee73b36a1920084232239f50d936a6b77cac22eabfd1eabd3fb4a8c1
• Download URL:
  https://stacks.cdc.gov/view/cdc/84553/cdc_84553_DS1.pdf
• File Type:
  [PDF - 182.74 KB ]